Expression of intermediate filaments in ovarian and uterine tumors
- PMID: 6193074
- DOI: 10.1097/00004347-198301040-00006
Expression of intermediate filaments in ovarian and uterine tumors
Abstract
We studied the expression of cytoskeletal intermediate filaments in different types of ovarian and uterine sarcomas and carcinomas. In both uterine and ovarian leiomyosarcomas, in endometrial stromal sarcomas, and also in ovarian sarcomas, most tumor cells appeared to be positive for desmin, the muscle type of intermediate filament protein. In most of the tumors, vimentin was present only in some neoplastic cells and in the vascular endothelia. Interestingly, both uterine and ovarian malignant mixed mesodermal tumors appeared to express several types of intermediate filaments, most of the stromal cells being positive for vimentin or desmin, and the epithelial component expressing keratin. The results show that most of the sarcomatous tumors of the ovary and uterus express mainly muscle type of intermediate filament protein. The results also demonstrate the ability of cells of mesodermal origin to express epithelial cytoskeleton markers--cytokeratins.
Similar articles
-
Immunocytochemical study of an endometrial diffuse clear cell stromal sarcoma and other endometrial stromal sarcomas.Cancer. 1987 Apr 15;59(8):1494-9. doi: 10.1002/1097-0142(19870415)59:8<1494::aid-cncr2820590817>3.0.co;2-v. Cancer. 1987. PMID: 2434209
-
Intermediate filament proteins in human testis and testicular germ-cell tumors.Am J Pathol. 1985 Sep;120(3):402-10. Am J Pathol. 1985. PMID: 2412445 Free PMC article.
-
Expression of intermediate filaments in soft-tissue sarcomas.Int J Cancer. 1982 Nov 15;30(5):541-6. doi: 10.1002/ijc.2910300502. Int J Cancer. 1982. PMID: 6185443
-
Cytoskeleton-associated proteins: their role as cellular integrators in the neoplastic process.Crit Rev Oncol Hematol. 1985;3(3):191-204. doi: 10.1016/s1040-8428(85)80026-3. Crit Rev Oncol Hematol. 1985. PMID: 2412718 Review.
-
Uterine sarcomas: a review.Gynecol Oncol. 2010 Jan;116(1):131-9. doi: 10.1016/j.ygyno.2009.09.023. Epub 2009 Oct 23. Gynecol Oncol. 2010. PMID: 19853898 Review.
Cited by
-
Use of immunohistochemical staining panel for characterisation of ovarian neoplasms.J Clin Pathol. 1988 Jan;41(1):12-6. doi: 10.1136/jcp.41.1.12. J Clin Pathol. 1988. PMID: 2449464 Free PMC article.
-
Demonstration of cytokeratin intermediate filaments in oocytes of the developing and adult human ovary.Histochemistry. 1993 Apr;99(4):311-9. doi: 10.1007/BF00269104. Histochemistry. 1993. PMID: 7684733
-
Immunohistochemistry of ovarian granulosa cell tumours. The value of tissue specific proteins and tumour markers.Virchows Arch A Pathol Anat Histopathol. 1989;414(5):439-45. doi: 10.1007/BF00718628. Virchows Arch A Pathol Anat Histopathol. 1989. PMID: 2471350
-
Immunohistochemical differentiation between ovarian granulosa cell tumors and ovarian carcinomas.Arch Gynecol Obstet. 1991;249(4):173-7. doi: 10.1007/BF02390384. Arch Gynecol Obstet. 1991. PMID: 1665684
-
Coexpression of cytokeratins and vimentin in common epithelial tumours of the ovary: an immunocytochemical study of eighty-three cases.Virchows Arch A Pathol Anat Histopathol. 1988;413(2):91-101. doi: 10.1007/BF00749670. Virchows Arch A Pathol Anat Histopathol. 1988. PMID: 2455381
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical